Status:
COMPLETED
Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy
Lead Sponsor:
Royal Brisbane and Women's Hospital
Conditions:
Parkinson's Disease
Multiple System Atrophy
Eligibility:
All Genders
40-95 years
Phase:
PHASE1
Brief Summary
Patients with Parkinson's Disease or Multiple System Atrophy (MSA), and symptoms of orthostatic hypotension, are eligible for the study. Each patient will have three weeks of conservative therapy, thr...
Detailed Description
Enrolled patients, ages 40-95, must have Parkinson's or MSA, diagnosed by a neurologist, and symptoms of orthostatic hypotension. Each patient will fill out two validated questionnaires to determine i...
Eligibility Criteria
Inclusion
- Patients residing in Queensland Australia
- Age 40-95
- Parkinson's Disease or MSA diagnosed by a neurologist
- Symptoms of orthostatic hypotension, as defined by 2 validated questionnaires
Exclusion
- Patients with acute cardiomyopathy or cardiac condition
- Patients unable to give consent
- Patients not stable on their Parkinsonian medications
- Patients with another cause for autonomic neuropathy
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00103597
Start Date
January 1 2005
End Date
September 1 2005
Last Update
October 20 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Brisbane and Women's Hospital
Brisbane, Queensland, Australia, 4029